China Resources Pharmaceutical Group
Tracked across 1 events · 8 articles · First seen Apr 10, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: China Resources Pharmaceutical Group, as the parent company of Dong-E-E-Jiao, views this collaboration as a key initiative to advance the modernization of Traditional Chinese Medicine (TCM) through AI integration, leveraging resources from Mainland China and China — Hong Kong.
Apr 10, 2026 · 8 articles
ERGEN INTELLIGENCE
Track China Resources Pharmaceutical Group live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard